CDC Officials Speculate on Johnson & Johnson COVID Vaccine Complication
Officials from the Food and Drug Administration and Centers for Disease Control and Prevention held a press conference Tuesday morning after announcing a “pause” in the use of the Johnson & Johnson COVID vaccine. The pause, FDA Center for Biologics Evaluation and Research Director Peter Marks explained, was brought about by “a rare type of blood clot known as…
